Adm R K Dhowan is also likely to take a closer look at the submarine building assembly line at the Naval Dockyard co-located with the Eastern Naval Command, on his maiden visit to a field command since taking over, reports RS Chauhan.
Dispatch of the vaccine is likely to start by early Tuesday morning, sources said. According to the order placed, each dose of the vaccine has been priced at Rs 200 and with GST of Rs 10, it would cost Rs 210.
Covaxin is being developed by Bharat Biotech jointly with the Indian Council of Medical Research (ICMR)- National Institute of Virology (NIV). The Phase III human clinical trials of Covaxin began mid-November, targeted to be done in 26,000 volunteers and it is the country's first and only Phase III efficacy study for a COVID-19 vaccine, a press release from the vaccine maker said on Saturday night.
At least 40% of a product must be manufactured in India for it to qualify for the Indian Designed, Developed and Manufactured category.
Safety and Efficacy results from the final analysis will be available in June, and the final report will be submitted to a peer-reviewed publication.
Defence Minister A K Antony has shot down Commerce Ministry's proposal to raise Foreign Direct Investment in defence from 26 per cent to 49 per cent, saying it will be a "retrograde" step and "stymie" the growth of the domestic industry while increasing dependence on foreign manufacturers.
The latest avatar of the F-15 is designed to deal with the world's most potent air threats that are emerging from China.
Wearing a G suit, the minister buckled himself in the seat behind the pilot in the aircraft.
'A month after assuming charge, Parrikar promised a policy within six months to "end or at least reduce" terrorist infiltration across the Line of Control.' 'However, infiltration continued apace, leading to high-profile terrorist attacks in Gurdaspur, Pathankot, and Uri.' 'During this phase, he made the controversial suggestion that India should fight terror with terror, hinting at supporting terror groups to strike in Pakistan,' observes Ajai Shukla.
India has over 4,000 medium tanks, but not a single light tank. It remains to be seen whether the Ladakh face-off with China galvanises a change, observes Ajai Shukla.
TAL Manufacturing Solutions expects its indigenously made affordable industrial robot, the Brabo, to boost the robotics vertical and contribute almost 40 per cent of its overall revenues in the next five years. Sohini Das reports.
Sputnik V is the third vaccine India has given the go-ahead to after 'Covishield', developed by Oxford University and AstraZeneca and 'Covaxin', the indigenous vaccine manufactured by Bharat Biotech. Covishield is manufactured by the Serum Institute of India.
'Wherever in the world there is political instability, those countries are beset with severe crises today. But India is in a much better position than the rest of the world due to the decisions taken by my government in the national interest,' President Droupadi Murmu said in her address to both Houses of Parliament.
The procurement and distribution will be centralised though the government is yet to take a call on the initial number of doses that will be procured.
Boeing is likely to vie for the deal to supply 110 fighter jets to the IAF in one of the biggest such procurement in recent years globally which could be worth over USD 15 billion.
HCL Technologies on Monday said its founder Shiv Nadar will take on the role of Chairman Emeritus and Strategic Advisor to the company's board. Nadar, chief strategy officer and managing director of the company, on completing 76 years of age, has tendered his resignation as the MD as well as the Director with effect from close of business hours on July 19, according to a regulatory filing. "In order to continue to benefit from his vast knowledge, experience, and wisdom in an advisory role, the Board of Directors in its meeting held today, after considering the recommendations of the Nomination & Remuneration Committee, has approved the appointment of Shri Shiv Nadar as the 'Chairman Emeritus and Strategic Advisor to the Board' for a term of five years with effect from July 20, 2021," it added.
According to health ministry officials, over 92 per cent of the adult population have received at least one dose while over 68 per cent have been fully vaccinated.
Modi cautioning that cryptocurrency can spoil the youth.
Laws governing compensation in case of adverse side effects for Covaxin and Covishield may differ in accordance with the kind of approvals given, say legal experts.
Along with HAL, Boeing intends to involve the Mahindra Group in building Super Hornets in India.
'Our sensors allow the missile to locate and identify the target even if it's on the move.'
As for Bharat Biotech, the Subject Expert Committee (SEC) on COVID-19 of the CDSCO asked the firm to expedite volunteer recruitment for the ongoing clinical trial and said it may conduct interim efficacy analysis for further consideration of restricted emergency use approval for its vaccine Covaxin, they stated.
During the webinar, 'COVID-19: Vaccination and Potential Return to Normalcy - If and When', Dr Hotez, an internationally-recognised physician-scientist in neglected tropical diseases and vaccine development, said that the COVID-19 vaccine rollout is "India's gift' to the world in combating the virus.
Cadila, Biocon developing rapid antibody testing kits; Eris, Mylan, Gland importing. There are two kinds of testing for the novel coronavirus - the real-time polymerase chain reaction test kit that uses throat or nasal swabs and provides results in a few hours, and the other is antibody-based rapid testing kit that use blood samples and provides results in a few minutes.
The missile was launched from a mobile autonomous launcher at 11.45 am and it successfully flew in its pre-set trajectory 'fulfilling its mission objectives', the ministry said.
What the new defence minister does with the Rafale fighter jet deal will decide if India wants to build genuine, long-term defence capability through an indigenous product that slashes life-cycle costs, or opt for glitzy signing ceremony with foreign vendors that would please the public, says Ajai Shukla.
"Three 155 mm howitzers (Dhanush) have been handed over to the army recently for user's trial," GCF's Joint General Manager and PRO Sanjay Shrivastava told PTI today.
Each vaccination session will cater to a maximum of 100 beneficiaries and the Union Health Ministry has advised states not to organise 'unreasonable numbers of vaccination per site per day'.
Millions of people across the country stayed indoors on March 22, 2020 in an unprecedented and overwhelming response to Prime Minister Narendra Modi's appeal for the nationwide curfew. People used to come out briefly at 5 pm to show their gratitude to healthcare and other essential service providers with sounds of bells, conches and claps.
Over the last four days, the Indian arm of US pharmaceutical giant Pfizer, Pune-based Serum Institute of India and Hyderabad-based pharmaceutical firm Bharat Biotech have applied to the Drugs Controller General of India seeking emergency use authorisation for their COVID-19 vaccines.
The Pune-based vaccine major has entered into a collaboration with the University of Oxford and AstraZeneca to manufacture the vaccine.
After the UPA tried unsuccessfully since 2010 to raise the 26 per cent cap on foreign direct investment (FDI) in defence production, a move that indigenous defence companies and former Defence Minister AK Antony resisted staunchly, the new government has initiated a fresh attempt along the same lines.
'The prioritisation of groups for COVID-19 vaccine shall be based on two key considerations -- occupational hazard and risk of exposure to infection, and the risk of developing severe disease and increased mortality'
Amongst those who heard the message of the Bihar results would be Defence Minister Manohar Parrikar, whose realm is simultaneously the country's most complex and -- when something goes wrong -- the most emotive, says Ajai Shukla.
A second wave of Covid driven by the Delta variant engulfed the country in May-June bringing the health system to its knees and leaving people gasping for help.
The judgment could impact not only Ramdev's widespread ayurveda and herbal products business, but also that of many other pharmaceutical, ayurveda, herbal and cosmetic product manufacturers.
The Union home ministry on May 13 had declared that these canteens will only sell indigenous or "swadeshi" products from June 1 in a bid to give fillip to domestic industries.
The prospects of India becoming a credible manufacturer of defence platforms or major weapon systems for export are remote, says Vice Admiral Premvir Das (retd).
The EC said that the data should be deleted by health authorities once the vaccination exercise concludes.
The vaccine maker Bharat Biotech said in a statement that preliminary reviews indicated that the death was unrelated to Covaxin.
© 2026 Rediff.com - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances